Endocrine modulation with positive modulators of AMPA type glutamate receptors
US6620808B2 · kind B2 · utility
14Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 2001 |
| Grant date | Sep 16, 2003 |
| Priority date | — |
| Expiry date | Sep 25, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for modulating the endocrine system of a mammal are provided. In the subject methods, a positive allosteric modulator of AMPA receptors of the hypothalamus are administered to the host. The subject methods find use in applications where it is desired to increase the circulatory level of a hormone in a mammalian host, such as diseased states characterized by abnormally depressed circulatory levels of the hormone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.